Novel ibuprofen prodrug: A possible promising agent for the management of complications of Alzheimer’s disease

Anjali Nayak; Rashu Raju; Paramita Das; Kuntal Das; A. Suvitha; Biswa Ranjan Meher; Saad Alobid; Ali Ibrahim Almoteer; Moneer E. Almadani; Ahmed Alshehri; Adel Alghamdi; Fuzail Ahmad; Syed Imam Rabbani; Syed Mohammed Basheeruddin Asdaq; Naira Nayeem

doi:10.1016/j.jsps.2023.101888

Citations

391

Views

Abstract not available for this publication.

Cite this Article (APA)

Anjali, N., Rashu, R., Paramita, D., Kuntal, D., A., S., Biswa, R. M., Saad, A., Ali, I. A., Moneer, E. A., Ahmed, A., Adel, A., Fuzail, A., Syed, I. R., Syed, M. B. A., Naira, N. (2024). Novel ibuprofen prodrug: A possible promising agent for the management of complications of Alzheimer’s disease. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2023.101888